• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 4 fuera de 159 páginas
Examen

WGU D027 Advanced Pathopharmacological Foundations Test Bank – Complete Questions & Verified Answers 2025/2026 PDF Study Guide

Document preview thumbnail
Vista previa 4 fuera de 159 páginas

This comprehensive exam bank contains high-yield, most-tested questions covering the WGU D027 Advanced Pathopharmacological Foundations course blueprint for the 2025/2026 academic year. Each question includes a verified, updated answer with a detailed rationale, covering pharmacokinetics, pharmacodynamics, cardiovascular pathopharmacology, pathophysiology across systems, and clinical decision-making with case studies.

Vista previa del contenido

WGU D027 Advanced Pathopharmacological Foundations
Test Bank – Complete Questions & Verified Answers
2025/2026 PDF Study Guide

INTRODUCTION
This question bank is designed for nursing students preparing for the WGU D027
Advanced Pathopharmacological Foundations assessment and related advanced
pathophysiology and pharmacology course exams at universities across the
United States. It contains 300 unique, non-repetitive multiple-choice questions
with verified answers and detailed rationales, covering the full exam blueprint:
pharmacokinetics and pharmacodynamics (absorption, distribution, metabolism,
excretion, half-life, steady state, first-pass metabolism, protein binding, CYP450
interactions, zero-order and first-order kinetics, receptor theory, agonists,
antagonists, partial agonists, therapeutic index), cardiovascular
pathopharmacology (heart failure, valvular disorders, murmurs, hypertension,
anticoagulants, antiarrhythmics, diuretics, beta-blockers, calcium channel
blockers, ACE inhibitors, ARBs, ARNIs), pathophysiology across systems (cellular
injury, inflammation, immunity, hypersensitivity reactions, genetic disorders,
cancer, respiratory disorders, endocrine disorders, renal disorders,
gastrointestinal disorders, neurologic disorders including Alzheimer's,
Parkinson's, and Fragile X-associated disorders), and clinical decision-making with
case studies (pain management, post-operative complications, electrolyte
imbalances, fluid resuscitation, medication interactions, DKA management,
hypertensive emergencies, myocardial infarction, opioid overdose, and more).

,SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
Which pharmacokinetic process is most affected by decreased hepatic
function?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion
Correct Answer: C
Rationale: The liver is the primary site of drug metabolism. Impaired
hepatic function reduces metabolism, prolonging drug half-life and
increasing toxicity risk.


Question 2
A patient with renal failure requires dosage adjustments for which type of
medication?
A) Drugs excreted unchanged by the kidneys
B) Drugs metabolized by the liver
C) Topical corticosteroids
D) Sublingual nitroglycerin
Correct Answer: A

,Rationale: Drugs primarily cleared unchanged through the kidneys
accumulate when renal function declines, requiring dosage
reduction.


Question 3
Which receptor type is primarily targeted by beta-blockers?
A) Alpha-1 adrenergic
B) Beta-adrenergic
C) Muscarinic
D) Dopaminergic
Correct Answer: B
Rationale: Beta-blockers block beta-adrenergic receptors in the
heart, reducing heart rate, myocardial contractility, and blood
pressure.


Question 4
Which adverse effect is most associated with aminoglycoside antibiotics?
A) Hepatotoxicity
B) Ototoxicity and nephrotoxicity
C) Cardiotoxicity
D) Hypotension
Correct Answer: B

, Rationale: Aminoglycosides (e.g., gentamicin) can cause renal
tubular damage and hearing loss due to toxicity.


Question 5
Which of the following best defines first-pass metabolism?
A) Drug metabolism occurring in the kidney before systemic circulation
B) Degradation of oral drugs in the liver before reaching systemic
circulation
C) Distribution of the drug in fatty tissues
D) The rate of absorption in the intestine
Correct Answer: B
Rationale: First-pass metabolism occurs in the liver, reducing
bioavailability of oral medications.


Question 6
Which medication is contraindicated in pregnancy due to teratogenicity?
A) Heparin
B) Warfarin
C) Insulin
D) Levothyroxine
Correct Answer: B

Información del documento

Subido en
25 de septiembre de 2026
Número de páginas
159
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$29.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
PROFEXAMINAR
4.9
(1023)
Vendido
302
Seguidores
192
Artículos
1020
Última venta
1 día hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes